SPID ®-Technology utilizes compartmentalization to enable sequential release of carbidopa and levodopa, offering a potential new approach for drug delivery in Parkinson’s disease treatment. "Levodopa ...

In the absence of a cure, the primary goals in managing Parkinson’s disease (PD) are to preserve functionality and health-related quality of life. Meeting these goals can minimize ...

Carbidopa 37.5mg, levodopa 150mg, entacapone 200mg; tabs. Administration of dopamine is ineffective in the treatment of Parkinson's disease because it does not cross the blood-brain barrier. However, ...

Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications. Mounting evidence ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study, which are being presented at the ...

One effective strategy for using Parkinson’s drugs is to start with a dopamine agonist. Explain to patients that this is the background dosing they will take on a regular schedule. Begin with a ...

DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease · In a clinical trial, patients treated with DUOPA ...

I read the article, “New drug options for neurologic disorders” (May 2010) with considerable interest because the problems these medications are designed to treat are of growing concern. However, I ...

Carbidopa, levodopa; 25mg/100mg, 50mg/200mg. Administration of dopamine is ineffective in the treatment of Parkinson’s disease apparently because it does not cross the blood-brain barrier. However, ...

CHICAGO – The drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects, ...

Levodopa is the most effective treatment to ameliorate motor symptoms of PD. When administered alone, its peripheral conversion to dopamine by dopa decarboxylase (DDC) causes nausea and vomiting by ...